|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
The 21st Century Cures Act’s Impact on Medical Devices: What You Need to Know to Thrive in 2017
Want to attend the live webinar on Jan. 26? Click here to register.
The passage of the 21st Century Cures Act means you will be scrambling to meet new mandates… regulations and guidances in several key areas — including data development and maintenance, technical support, clinical approvals, breakthrough devices, device inspections and reviews, and humanitarian device exemptions.
Join legal expert Jim O’Reilly for a discussion on the biggest change in the daily activities of the device regulatory community in four decades.
After this 90-minute session you’ll understand:
Order today and learn what has changed with the 21st Century Cures Act and what you need to watch for in your submissions to the FDA.
Jim O’Reilly, Retired Law Professor, University of Cincinnati College of Law
Longtime food and drug law professor Jim O’Reilly was quoted by the U.S. Supreme Court in a 2000 FDA medical device case as “the expert” on device law. He is the last surviving member of the small group which negotiated in 1975-76 for the Medical Device Amendments, and his 3-volume treatise for West “Food & Drug Administration” is used around the world by regulated firms. He chairs the FDA Committee of the American Bar Association and served for many years as program chair for conferences produced by the Food and Drug Law Institute. He served on the Editorial Advisory Board of FDLI’s Food and Drug Law Journal and has published 53 texts and 215 articles.
Copyright ©2017. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing